Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimazolam alone or with dexmedetomidine vs propofol for painless bronchoscopy
ChiCTR2000041435Phase 4Recruiting
- Sponsor
- GaoSheng Biopharma
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (3 arms), sponsored by GaoSheng Biopharma. Primary endpoints: Cough score and Incidence of hypoxemia. Started Jan 2021; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2000041435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041435.